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Active breaks in prolonged sitting has beneficial impacts on cardiometabolic risk biomarkers. The 
molecular mechanisms include regulation of skeletal muscle gene and protein expression controlling 
metabolic, inflammatory and cell development pathways. An active communication network exists 
between adipose and muscle tissue, but the effect of active breaks in prolonged sitting on adipose 
tissue have not been investigated. This study characterized the acute transcriptional events induced 
in adipose tissue by regular active breaks during prolonged sitting. We studied 8 overweight/obese 
adults participating in an acute randomized three-intervention crossover trial. Interventions were 
performed in the postprandial state and included: (i) prolonged uninterrupted sitting; or prolonged 
sitting interrupted with 2-minute bouts of (ii) light- or (iii) moderate-intensity treadmill walking every 
20 minutes. Subcutaneous adipose tissue biopsies were obtained after each condition. Microarrays 
identified 36 differentially expressed genes between the three conditions (fold change ≥0.5 in either 
direction; p < 0.05). Pathway analysis indicated that breaking up of prolonged sitting led to differential 
regulation of adipose tissue metabolic networks and inflammatory pathways, increased insulin 
signaling, modulation of adipocyte cell cycle, and facilitated cross-talk between adipose tissue and 
other organs. This study provides preliminary insight into the adipose tissue regulatory systems that 
may contribute to the physiological effects of interrupting prolonged sitting.
Prolonged uninterrupted sitting is positively associated with cardiometabolic risk biomarkers and premature 
mortality, independent of moderate-to-vigorous intensity physical activity1. There is emerging interest in the 
underlying biological responses to prolonged sitting that may drive disease pathophysiology, and how break-
ing up sitting with short, regular bouts of physical activity can potentially act to mitigate these adverse effects. 
Studies examining beneficial effects of breaking up sedentary time have implicated regulation of postprandial 
glucose, insulin and lipid metabolism2–4, endothelium-mediated arterial vasodilation5–7, and anti-inflammatory 
mechanisms8–11.
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The mechanistic underpinnings of the beneficial effects of breaking up prolonged sitting are likely to be mul-
tifactorial, and involve peripheral organs that are known to play a key role in metabolism, such as skeletal muscle, 
liver and adipose tissue. Our group has observed favourable changes in skeletal muscle gene and protein expres-
sion that likely contribute to the improved glucose control associated with breaking up of prolonged sitting via 
light- or moderate-intensity activities. These changes include some which align with, and others which may be 
distinct from, the effects of continuous acute exercise12,13.
Subcutaneous white adipose tissue is another important metabolic regulatory tissue that may be a central 
mediator of the cardiometabolic effects of breaking up prolonged sitting time. In addition to its key role in lipid 
storage, factors secreted from white adipose tissue play pivotal roles in appetite regulation, energy homeostasis, 
insulin sensitivity, inflammation, and immunological responses14,15. Excessive accumulation of visceral adipose 
tissue positively associates with increased cardiometabolic disease risk16. While the role of subcutaneous adipose 
tissue in disease pathophysiology is less clear, it has also been associated with increased disease risk17–23.
Storage of excess lipid in subcutaneous adipocytes has been driven by the vital physiological roles of lipids; 
including as structural elements in plasma membranes, second messengers and energy substrates. However, 
upon exceeding storage capacity of subcutaneous adipocytes, lipid accumulates in visceral adipose and eventually 
ectopically in metabolic regulatory organs17. Ectopic lipid accumulation has been well established as a contributor 
to low-grade inflammation, endoplasmic reticulum stress and tissue insulin resistance17. In adipose tissue, insulin 
resistance is characterized by reduced glucose uptake, impairment in both lipogenesis and insulin-stimulated 
inhibition of lipolysis14,24. Thus, insulin resistance increases lipid availability to visceral and ectopic sites, contrib-
uting to increased cardiometabolic risk14.
Acute exercise protects against ectopic lipid accumulation by oxidising fatty acids for ATP production and 
enhancing insulin sensitivity in multiple tissues. In adipose tissue, exercise training also reduces inflammation 
and increases glucose uptake through pathways which have been well characterized25. To date, studies have typ-
ically focused on understanding the impact of continuous exercise bouts on gene and protein expression. Few 
studies have investigated whether regular active breaks from prolonged sitting modulate similar pathways13,26, 
and the effects of breaks from prolonged sitting on adipose tissue are unknown. In a previous study we showed 
that, compared to uninterrupted sitting, frequent brief bouts of either light- or moderate-intensity walking low-
ered acute postprandial glucose and insulin responses2. An ancillary analysis of vastus lateralis muscle collected 
from 8 participants in the main study showed that those brief interruptions to sitting time resulted in upregula-
tion of genes involved in cell development, glucose uptake, and anti-inflammatory pathways; and, downregula-
tion of genes associated with protein degradation and muscle atrophy13.
In this investigation, we now aim to define the acute transcriptional events induced in subcutaneous adipose 
tissue by regular brief active interruptions to prolonged sitting time, using subcutaneous abdominal adipose 
tissue collected from the same subset of 8 participants in the skeletal muscle-tissue study described above2,13. 
We hypothesized that interrupting sitting time with brief, intermittent activity bouts of either light or moderate 
intensity would change expression of genes involved in substrate metabolism and inflammation, relative to pro-
longed sitting.
Methods
Study Overview. This randomized, three-intervention crossover trial was conducted in accordance 
with the Declaration of Helsinki and approved by the Alfred Health Human Research Ethics Committee 
(Melbourne, Australia). The study is registered with the Australian and New Zealand Clinical Trials Registry 
(ACTRN12609000656235, 04/08/2009) and participants provided written, informed consent.
A detailed description of the participant characteristics, screening and testing procedures for the full study 
have been previously described2 and the relevant aspects of the study design and protocol are summarised in 
Fig. 1. Of the 19 participants in the main study, eight (7 male, 1 female) consented to subcutaneous adipose biop-
sies, and are included in the current investigation. The inclusion criteria were: age 45–65 years, body mass index 
(BMI) 25–45 kg/m2. Participants were excluded if they had a diagnosis of diabetes, were taking glucose and/or 
lipid-lowering medication, or were regularly engaged in moderate intensity exercise ≥150 minutes/week for at 
least 3 months. They attended three study visits at the Baker Heart and Diabetes Institute to complete the study 
conditions in a randomized order2. Study conditions were as follows:
Figure 1. Study design and protocol.
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 (1) Uninterrupted sitting. Participants remained seated throughout the experimental period and were instruct-
ed to minimize excessive movement, only rising from the chair to void.
 (2) Sitting interrupted with light intensity walking breaks. Participants rose from the seated position every 
20 minutes throughout the experimental period (3 breaks per hour) and completed a 2-minute bout 
of light intensity walking (3.2 km/h) on a motorized treadmill on a level surface. The participants then 
returned to the seated position. This procedure was undertaken on 14 occasions, providing a total of 
28 minutes of light-intensity activity.
 (3) Sitting interrupted with moderate intensity walking breaks. Identical to the light intensity walking breaks 
condition, but participants completed 2 minute bouts of moderate-intensity walking (5.8–6.4 km/h) on 
the treadmill, providing a total of 28 minutes of moderate-intensity activity. The speed of walking for this 
condition was based on individual perception of activity intensity, determined at a familiarisation session, 
and based on a Borg Rating of Perceived Exertion between 12 and 142.
A minimum washout period of 6 days between each condition was imposed to avoid potential confound-
ing effects since an acute bout of activity may enhance insulin sensitivity for up to 72 hours. Participants were 
instructed to refrain from any structured moderate-vigorous exercise, alcohol and caffeine in the 48 hours prior 
to each of the trial conditions. During this time, physical activity was monitored using an Actigraph GT1M accel-
erometer (Actigraph, Pensacola, FL), which was worn around the hip during waking hours.
Participants reported to the laboratory between 0700 and 0800 hours, having fasted from at least 2200 hours 
the night before. A cannula was inserted into an antecubital vein for hourly blood sampling. For all of the three 
experimental conditions, and following the initial blood collection (time point: −2 hours), they remained seated 
for 2 hours to achieve a steady state before consumption of a standardized test drink (time point: 0 hours). The 
200 mL test drink consisted of 75 g carbohydrate (100% corn maltodextrin powder, Natural Health) and 50 g fat 
(Calogen, Nuticia). The specific nutritional components were as follows: energy: 3,195 kJ; total fat: 50 g; saturated 
fat: 5 g; monounsaturated fat: 30.4 g; polyunsaturated fat: 14.3 g; total carbohydrate: 75 g; total sugars: 12.8 g; pro-
tein nil; fiber <1 g; sodium: 46.9 mg; and water: 90 g. Blood was sampled at baseline before drink consumption 
and hourly post drink consumption. The incremental area under the glucose-time, insulin-time and insulin/
glucose-time curves have been previously presented for the whole cohort2, and the 8 participants included in this 
sub-study13.
Adipose tissue biopsy. Abdominal subcutaneous adipose tissue biopsies were obtained using standard 
aseptic technique and local anaesthesia (lignocaine) approximately 40–50 minutes after the last activity bout, and 
5 hours after the drink ingestion (Fig. 1). During the first intervention visit, a 0.5–1 cm skin incision was made 
~5 cm lateral to the navel/umbilicus, and a Bergstrom biopsy needle passed through to obtain approximately 
1–2 cm3 of subcutaneous adipose tissue under suction. Biopsies taken at the second and third intervention trials 
were obtained from the side opposite that of the preceding trial and at the third trial >5 cm superior or inferior 
to the first to avoid the potential for sampling prior injured tissue. All biopsies were rinsed of blood in ice-cold 
sterile saline, the connective tissue removed and cleaned adipose tissue was snap frozen in liquid nitrogen for 
subsequent storage at −80 °C until further analysis.
RNA extraction. RNA isolation from 100 mg of adipose tissue was performed using TRIzol Reagent as per 
manufacturer’s instructions (ThermoFisher Scientific, Massachusetts, USA). The RNA phase (the clear upper 
aqueous layer) was transferred to a new tube without disturbing the interphase. Then 1.5 volumes of 100% etha-
nol was added to the samples and loaded onto the RNeasy mini spin column (Qiagen, Hilden, Germany). RNA 
was extracted according to the manufacturer’s protocol. The RNA was quantified using a Nanodrop spectro-
photometer (ThermoFisher Scientific, Massachusetts, USA) and Qubit fluorometer (ThermoFisher Scientific, 
Massachusetts, USA). The integrity of the RNA was assessed using a MultiNA Microchip Electrophoresis System 
(Shimadzu, Kyoto, Japan).
Gene Expression Profiling/Microarrays. The amplification and labelling of RNA was performed using 
the TotalPrep amplification kit according to manufacturer’s instructions (Ambion; ThermoFisher Scientific 
Massachusetts, USA). The labelled samples were hybridized to the Human HT-12 v4.0 Expression BeadChip 
as per the manufacturer’s protocol (47,231 probes; Illumina, California, USA). The BeadChips were scanned 
using the iScan microarray BeadStudio platform (Illumina, California, USA). Quality standards for hybridization, 
labelling, staining, background signal, and basal level of housekeeping gene expression for each chip were verified. 
After scanning on the Illumina iScan, the resulting images were background subtracted, quantile normalized 
and processed using the GenomeStudio software (Illumina, California, USA). Data files were deposited into the 
National Center for Biotechnology Information Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc = GSE115645).
An Illumina detection P-value of <0.05 was used to determine presence or absence of a probe in each tissue 
sample. Call rates for each of the three study conditions were then calculated for each gene, per condition using 
equation 1:
=
< .Call rate number of adipose samples with a detection p value
total number of adipose samples
0 05
(1)
A gene was included in the subsequent analysis if a call rate of ≥0.5 was calculated for at least one condition. 
Analysis of the effects of activity breaks versus prolonged sitting was performed in Stata (StataCorp, College 
Station, TX). To identify genes with the most marked changes in expression level, we applied an absolute fold 
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change threshold of ≥0.5 (in either direction from 1) for any of the three experimental condition pairs (light 
intensity breaks versus uninterrupted sitting; moderate intensity breaks versus uninterrupted sitting; moderate 
versus light intensity breaks), where a fold change <1 refers to downregulation and >1 refers to upregulation of 
the gene relative to the comparator condition. This approach has been previously validated27, showing close qual-
itative and quantitative relationships to qPCR, including in skeletal muscle from this same study13.
Statistical Analysis. Linear mixed models accounting for dependency in the data (repeated measures) were 
used to evaluate the differential effects of the trial conditions on expression of genes. All models were adjusted for 
age and BMI. P-values for the overall condition variable were obtained from post-hoc Wald tests and corrected for 
multiple comparisons using the False Discovery Rate (FDR) method of Benjamini-Hochberg28. Post hoc, pairwise 
analyses were performed using post-estimation commands of the linear mixed model, and the resultant pair-
wise P-values were corrected by the Dunn-Sidak approach. A corrected P-value of <0.05 was considered to be 
statistically significant. All statistical analyses were performed using Stata 14.1 for Windows (StataCorp, College 
Station, TX).
Pathway analysis. Genes were ranked using a signed log10-transformed P-value (from the linear mixed 
model analysis) with the sign denoting the direction of change, positive for increasing and negative for decreas-
ing29. The rank score for genes that were represented by more than one transcript, was calculated for the tran-
script with the lowest P-value, and the others were disregarded. The ranked gene list was inputted into GSEA 3.0 
software (Broad Institute, Cambridge, MA). A normalized enrichment score (NES), the degree to which a gene 
set is overrepresented at the top or bottom of a ranked list of genes, was calculated30. NES scores greater than zero 
indicate upregulation of a pathway, whereas NES values of less than zero represent down regulation.
Gene sets with a P-value ≤ 0.1, following false discovery rate (FDR) correction, were considered likely to gen-
erate valid hypotheses and drive further research. Leading edge analysis was used to examine the genes that were 
in the leading-edge subsets of the enriched gene sets. The Reactome pathway database (www.reactome.org) was 
used to categorize genes by pathways to facilitate biological interpretation.
All analyses were performed in a blinded manner.
Results
Participant demographics and biochemical analyses for the eight participants recruited for this sub-study have 
been reported previously13. Those recruited for the present sub-study had a mean age of 55 ± 6 years and BMI 
30.9 ± 2.9 kg/m2 (mean ± SD). In the main study (n = 19), interrupting prolonged sitting with both light- and 
moderate-intensity walking significantly reduced postprandial glucose (by 24% and 30%, respectively) and insu-
lin (by 23% for both conditions) incremental area under the curve (iAUC), relative to uninterrupted sitting2. 
In the current subset of eight participants, there was a trend toward a decrease in glucose iAUC (−22% and 
−20%; P = 0.1) and a significant decrease in insulin iAUC (−25% and −23%; P < 0.05) in the light-intensity and 
moderate-intensity breaks conditions, respectively, relative to uninterrupted sitting13.
The microarray analysis identified 18,844 transcripts expressed in the adipose tissue. Of these, 469 satisfied 
the 0.5-fold change criteria (described in the Methods) in at least one out of the three comparisons between the 
experimental condition pairs. Thirty-six genes were significantly differentially expressed (FDR-adjusted P < 0.05; 
Table 1, Fig. 2). Of these, 7/36 genes were upregulated and 2/36 genes were downregulated in the light-intensity 
breaks condition, compared to uninterrupted sitting; 1/36 genes was upregulated and none were downregulated 
in the moderate-intensity breaks condition compared to uninterrupted sitting; and, 29/36 genes were upregulated 
and none were downregulated in the moderate-intensity breaks condition compared to the light-intensity breaks 
(Table 1).
Analysis of the ranked gene list identified 102 differentially (up- or down-) regulated pathways, with an 
FDR-adjusted P ≤ 0.10 (Fig. 3, Supplementary Table 1). In the light-intensity breaks condition, 64/102 pathways 
were upregulated and 19/102 were downregulated, compared to uninterrupted sitting. In the moderate-intensity 
breaks condition, 11/102 pathways were upregulated and 0/102 were downregulated, compared to uninterrupted 
sitting; and, 23/102 pathways were upregulated and 42/102 were downregulated, compared to light-intensity 
breaks. Among the regulated pathways were those involved with metabolism of macronutrients, adenosine 
triphosphate (ATP) synthesis, immune function, signal transduction, extracellular matrix organisation and cell 
cycle.
Discussion
The major novel finding of this study is that actively breaking up prolonged sitting time in the postprandial state 
was associated with changes in the expression of subcutaneous abdominal adipose tissue genes and pathways 
involved in macronutrient metabolism and ATP synthesis, immune function, signal transduction, and cell cycle 
regulation. These changes are likely induced by systemic physiological drivers associated with physical activity 
and known to modulate adipose tissue function through multiple mechanisms including via the sympathetic 
nervous system, increased adipose tissue blood flow and changes in circulating factors including adrenaline, 
insulin and glucagon31. Interestingly, the majority of the differences were between the light-intensity activity, 
relative to both the uninterrupted sitting and the moderate-intensity breaks conditions. This may relate to the fact 
that of all the interventions studied, light intensity breaks would be most dependent on fat metabolism (adipose 
tissue)32,33. By contrast, moderate intensity breaks which would have been more reliant on glucose metabolism, 
had relatively few differentially regulated genes and pathways in comparison to prolonged uninterrupted sitting.
Active breaks during prolonged sitting alter adipose expression of metabolic regulatory net-
works controlling ATP synthesis. Consistent with fat oxidation being the major pathway for ATP pro-
duction induced by low-intensity activity, upregulation of genes and pathways associated with enhanced capacity 
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for lipid oxidation were observed for the light-intensity breaks condition in comparison to both the uninter-
rupted sitting and moderate-intensity breaks conditions (Figs 2 and 3). Mitochondrial (tricarboxylic acid cycle 
and respiratory electron transport) and peroxisomal β-oxidation pathways were upregulated in the light-intensity 
breaks condition. The key functional difference between these compartmental processes is that mitochon-
drial β-oxidation generates acetyl-CoA and reduced cofactors via degradation of energy substrates, primarily 
long-chain fatty acids, which is coupled to oxidative phosphorylation; whereas, peroxisomes degrade a wide vari-
ety of lipophilic compounds that have important functions not involved in ATP resynthesis34. Although it did not 
reach the fold-change cut-off for the main analysis (1.45 fold change compared to uninterrupted sitting), upreg-
ulation of the NDUFAB1 (NADH:Ubiquinone Oxidoreductase Subunit AB1) gene was identified in the path-
way analysis for the light-intensity breaks condition. This non-catalytic accessory subunit of the mitochondrial 
Gene Symbol
Overall 
condition Light vs Sit Mod vs Sit Mod vs Light
DefinitionP Value
Fold 
Change P Value
Fold 
Change P Value
Fold 
Change P Value
APBB3 0.037 0.62 0.001 1.08 0.92 1.74 0.0001 Amyloid beta precursor protein binding family member 3
CLDN15 0.044 0.59 0.0006 1.01 1.00 1.72 0.0004 Claudin 15
CLEC4GP1 0.033 0.72 0.004 1.11 0.67 1.53 <0.0001 C-type lectin domain family 4 member G pseudogene 1
CLK2 0.0008 0.68 <0.0001 1.07 0.84 1.57 <0.0001 CDC like kinase 2
CPLX1 0.030 0.48 0.0001 0.90 0.91 1.87 0.001 Complexin 1
GDPD3 0.006 0.57 <0.0001 0.95 0.97 1.68 0.0001 Glycerophosphodiester phosphodiesterase domain containing 3
HUWE1 0.001 0.67 <0.0001 1.07 0.84 1.60 <0.0001 HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase
ID1 0.004 0.62 <0.0001 0.99 1.00 1.58 <0.0001 Inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
KIAA0922 0.011 0.66 <0.0001 0.99 1.00 1.50 0.0001 Transmembrane 131 like
LOC100133930 0.0005 0.58 <0.0001 0.92 0.84 1.60 <0.0001 Similar to D-2-hydroxyglutarate dehydrogenase
LOC653658 0.006 1.73 <0.0001 1.27 0.092 0.73 0.016 Ribosomal protein S23 pseudogene 8
LOC728590 0.030 1.59 <0.0001 1.47 0.002 0.92 0.86 Ribosomal protein S27a pseudogene 11
LOC729200 0.006 1.62 <0.0001 1.13 0.56 0.70 0.001 Small nuclear ribonucleoprotein polypeptide B2 pseudogene
LTB4R 0.030 0.69 0.001 1.06 0.92 1.54 0.0001 Leukotriene B4 receptor
LUC7L 0.032 0.64 0.0003 0.99 1.00 1.54 0.0004 Luciferase 7 like
MAN2C1 0.008 0.59 <0.0001 1.01 1.00 1.70 <0.0001 Mannosidase alpha class 2C member 1
MCF2L 0.008 0.54 <0.0001 0.89 0.78 1.66 0.0006 MCF2 transforming sequence-like protein
MSH5 0.001 0.71 0.0002 1.09 0.68 1.53 <0.0001 MutS homolog 5
MTCP1 0.027 1.73 <0.0001 1.20 0.38 0.69 0.008 Mature T-cell proliferation 1
MYO1C 0.0003 0.64 <0.0001 0.98 1.00 1.54 <0.0001 Myosin 1c
NOS3 0.013 0.51 <0.0001 0.88 0.80 1.72 0.0009 Nitric oxide synthase 3
PDGFB 0.015 0.62 <0.0001 0.95 0.94 1.52 0.0004 Platelet derived growth factor subunit b
PFKFB3 0.029 0.81 0.42 1.57 0.008 1.94 <0.0001 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
PKD1 0.0003 0.60 <0.0001 0.95 0.94 1.58 <0.0001 Polycystin 1, transient receptor potential channel interacting
PKD1L2 0.0005 0.56 <0.0001 1.00 1.00 1.79 <0.0001 Polycystin 1 like 2
PSMA3 0.0002 1.54 <0.0001 0.99 1.00 0.64 <0.0001 Proteasome subunit alpha 3
RGS11 0.045 0.54 0.0004 0.98 1.00 1.82 0.0006 Regulator of g protein signalling 11
RPL9 0.008 2.48 <0.0001 1.35 0.30 0.55 0.004 Ribosomal protein L9
SAFB 0.023 0.60 0.0002 1.00 1.00 1.67 0.0002 Scaffold attachment factor b
SPG7 0.040 0.68 0.002 1.07 0.92 1.57 0.0002 Spastic paraplegia 7, paralegin matrix AAA peptidase subunit
STAT1 0.010 1.60 <0.0001 1.16 0.36 0.73 0.004 Signal transducer and activator of transcription 1
TIE1 0.001 0.48 <0.0001 0.84 0.53 1.75 0.0003 Tyrosine kinase with immunoglobulin like and EGF like domains 1
TNFRSF25 0.0005 0.56 <0.0001 1.10 0.83 1.97 <0.0001 Tumour necrosis factor receptor superfamily member 25
ZBTB46 0.047 0.54 <0.0001 0.82 0.46 1.53 0.011 Zinc finger and BTB domain containing 46
ZNF767 0.030 0.70 0.002 1.10 0.75 1.57 <0.0001 Zinc finger family member 767, pseudogene
ZXDC 0.0008 0.64 <0.0001 1.02 1.00 1.59 <0.0001 ZXD family zinc finger C
Table 1. Genes differentially expressed between the three experimental conditions. Overall condition P value 
indicates the corrected false discovery rate P value for the post-hoc Wald test. Pairwise condition comparison P 
values are corrected by the Dunn-Sidak approach. Comparisons meeting the 0.5 fold change criteria (in either 
direction) and meeting the significance threshold are highlighted in bold: fold change comparisons < 1 indicate 
downregulation, and >1 upregulation of the gene relative to the comparison condition. Light vs Sit = light 
intensity breaks versus uninterrupted sitting; Mod vs Sit = moderate intensity breaks versus uninterrupted 
sitting; Mod vs Light = moderate intensity breaks versus light intensity breaks.
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membrane Complex I functions in the transfer of electrons from NADH to the respiratory chain, indicating 
an increased capacity for substrate oxidation. Significantly lower expression of ID1 and NOS3 (endothelial 
nitric oxide synthase, eNOS) in the light-intensity breaks condition, compared to the uninterrupted sitting and 
moderate-intensity breaks conditions, is also consistent with higher lipid oxidation. Deletion of the ID1 gene (a 
transcriptional regulator of helix-loop-helix transcription factors that control cell type-specific gene expression) 
in mice has been implicated in numerous physiological effects with potential metabolic benefit. It was found that 
loss of the ID1 gene leads to increases in expression of genes which promote fatty acid oxidation, with id1−/− mice 
also exhibiting reduced insulin resistance and fat mass while on a high fat diet, and increased oxygen consump-
tion compared to wild type mice35,36. Adipose eNOS expression is increased in obese adults, and has been impli-
cated in the inhibition of lipolysis via downregulation of lipolytic pathways37,38. Downregulation of eNOS (NOS3) 
expression in the light-intensity breaks condition may therefore also indicate an increase in lipolysis. The differing 
expression patterns between the two break conditions for genes regulating lipolysis occurred despite similarity 
in blood glucose and insulin levels, suggesting that mechanisms associated with activity break intensity such as 
adrenergic pathways may have been the predominant influence.
Reflecting the preponderance of lipid over carbohydrate metabolism for provision of ATP during 
light-intensity activity physical activity32,33, pathways linked to carbohydrate metabolism were downregulated 
in comparison to both uninterrupted sitting and moderate-intensity breaks. Here, significantly lower adi-
pose tissue NOS3 and MYO1C gene expression in the light-intensity breaks condition may indicate reduced 
insulin-dependent and -independent GLUT-4 translocation and subsequent glucose uptake39,40. In contrast, sig-
nificantly higher expression of PFKFB3 was observed in the moderate-intensity breaks condition compared to 
both the uninterrupted sitting and light-intensity breaks conditions. PFKFB3 is an enzyme whose product (fruc-
tose 2,6-biphosphate) is a powerful activator of the glycolytic enzyme 6-phosphofructo-1-kinase, the rate-limiting 
step in glycolysis41,42, indicating a greater capacity for glucose oxidation in the moderate-intensity breaks condi-
tion (Fig. 3).
Active breaks in prolonged sitting regulate anti-inflammatory and anti-oxidative stress path-
ways, and improve insulin sensitivity. Inflammatory and metabolic signaling are closely interlinked, 
such that chronic disturbance of metabolic homeostasis can lead to aberrant immune responses and inflamma-
tion; and, vice versa, where chronic inflammation can induce insulin resistance and metabolic dysfunction43. 
While a continuous moderate-to-high intensity exercise bout has been shown to activate inflammatory and 
Figure 2. Genes differentially expressed between the three experimental conditions. Heat map showing 
those genes up (blue) and down (green) regulated for comparisons of Light vs Sit (light intensity breaks versus 
uninterrupted sitting, column 1); Mod vs Sit (moderate intensity breaks versus uninterrupted sitting, column 
2) and Mod vs Light (moderate intensity breaks versus light intensity breaks, column 3). Comparisons meeting 
both the 0.5 fold change criteria (in either direction from 1) and the significance threshold are highlighted in 
Table 1. Refer to Table 1 for gene definitions.
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oxidative pathways44,45, we found little evidence for modulation of immune function or inflammatory status with 
the brief moderate-intensity breaks from sitting in the current study, compared to uninterrupted sitting (Fig. 3). 
In contrast, light intensity breaks from sitting appeared to upregulate immune function and downregulate inflam-
matory signals compared to the uninterrupted sitting and moderate-intensity breaks conditions.
Tumour necrosis factor alpha (TNFα), derived primarily from resident macrophages, is known to be overex-
pressed in adipose tissue of obese humans and mice46–48. TNFα is a pro-inflammatory cytokine that activates var-
ious signal transduction cascades, including pathways involved in inhibiting insulin action43,49,50. TNFα and other 
inflammatory cytokines impair insulin action by post-translational modification of insulin receptor substrate 1 
through serine phosphorylation, which interferes with the ability of this protein to engage in insulin-receptor 
signaling43. The ID1 gene has been suggested to be important in mediating the increased expression of TNFα in 
adipose tissue following a high-fat diet in mice36; the ID1 gene was downregulated in the light-intensity breaks 
compared to the moderate-intensity breaks condition. Receptors for TNFα play an important role in its down-
stream effects. Here, we also observed lower expression of the receptor TNFRSF25 in the light-intensity breaks 
condition; TNFRSF25 is known to stimulate NF-κB activity51. NF-κB inflammatory pathways contribute to the 
pathology of metabolic disorders52. Indeed, clinical trials have shown amelioration of insulin resistance and 
improved glucose homeostasis in type 2 diabetes patients treated with salicylates, which inhibit NF-κB activa-
tion53. Significantly lower expression of ID1 and TNFRSF25 in the light-intensity breaks condition compared to 
moderate-intensity breaks is suggestive of reduced production of TNFα and its downstream signaling. Despite 
not reaching the 1.5 fold change threshold, both the ID1 and TNFRSF25 genes were also significantly downregu-
lated in the light-intensity breaks condition compared to uninterrupted sitting.
The potent pro-inflammatory molecule LTB4 is highly expressed in obesity, and has recently been shown to 
directly induce insulin resistance at least partially through its receptor, LTB4R54–56. Here, we observed signif-
icantly lower expression of the LTB4R gene in the light-intensity breaks, compared to the moderate-intensity 
breaks condition. LTB4R was also statistically significantly downregulated in the light-intensity breaks condition 
compared to uninterrupted sitting though the 0.5 fold change threshold was not reached (0.69 fold change). 
Furthermore, the Notch signaling pathway was significantly downregulated in the light-intensity breaks con-
dition, compared to uninterrupted sitting and moderate-intensity breaks conditions. Notch signaling is highly 
conserved in mammals, and rodent studies indicate that inhibition of this pathway improves adipose tissue insu-
lin sensitivity57. Together, these results suggest that downregulation of inflammatory pathways involving TNFα, 
NF-κB, lipoxygenase and Notch signaling could contribute to the beneficial effects of breaking up sedentary time 
with light-intensity activities on metabolism by positively influencing adipose tissue insulin sensitivity.
Reactive oxygen species (ROS) are continuously produced as by-products of aerobic metabolism. ROS can act 
as important signaling molecules, but can also cause oxidative damage to cells and tissues, and their accumulation 
Figure 3. Pathways differentially regulated between the three experimental conditions. Heat map showing 
pathways up (blue, Normalized Enrichment Score (NES) >0) and down (green, NES <0) regulated for 
comparisons of Light vs Sit (light intensity breaks versus uninterrupted sitting, column 1); Mod vs Sit (moderate 
intensity breaks versus uninterrupted sitting, column 2) and Mod vs Light (moderate intensity breaks versus 
light intensity breaks, column 3). The significance of these comparisons are indicated in Supplementary 
Table 1. ATP = adenosine triphosphate; BCR = B cell receptor; ER = endoplasmic reticulum; MHC = major 
histocompatibility; Resp. electr. transp = respiratory electron transport; TCA = tricarboxcylic acid.
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is regulated by a complex system of anti-oxidative defences. In addition to β-oxidation, the peroxisomal lipid 
metabolism pathway is involved in the dynamic response to cellular stress. Peroxisomes contain a number of 
antioxidant defences involved in the regulation of ROS, including the synthesis of the ether phospholipid species 
plasmalogens58,59. We have previously shown that light-intensity breaks during prolonged sitting in adults with 
type 2 diabetes ameliorates the postprandial reduction in plasma plasmalogen species, compared to prolonged 
uninterrupted sitting4. The upregulation of peroxisomal lipid metabolism in the light-intensity breaks condition 
in the current study suggests that this may be partially due to increased biosynthesis of plasmalogen lipid species 
in the adipose tissue. This finding may provide an important mechanistic link between the protective effects of 
light-intensity breaks during prolonged sitting and risk of cardiometabolic diseases, as plasmalogens have been 
suggested to be protective against atherosclerosis60,61.
Active breaks in prolonged sitting regulate adipose tissue cell cycle pathways. Coupling of cell 
cycle progression and programmed cell death pathways are regulated to maintain tissue homeostasis. The cell 
cycle involves a cascade of events that leads to cell division and DNA replication. Progression of the cell cycle is 
orchestrated by regulatory (cyclins) and catalytic subunits (cyclin-dependent kinases, CDKs), as well as ubiquitin 
ligases (such as anaphase promoting complex, APC) which mark cell cycle proteins for degradation62,63. Here, we 
observed upregulation of several pathways related to cell cycle and DNA replication, concurrently with upreg-
ulation of apoptosis pathways, in response to light-intensity breaks from sitting versus uninterrupted sitting. 
These data suggest adaptation of adipocyte cell cycle in the light-intensity breaks condition. Cell cycle and DNA 
replication pathways also tended to be upregulated in the moderate-intensity breaks condition, in comparison to 
uninterrupted sitting, but in most cases did not reach statistical significance (P > 0.1, Table 2). Upregulation of 
the M, G1, and S phases of cell cycle involved in cell growth and proliferation, as well as pathways involved in the 
transition between these phases, indicates acute stimulation of adipogenesis pathways. Upregulation of check-
points also suggests greater quality control to prevent unhealthy cells from proliferating62.
Adipose cells dynamically adapt their growth and metabolism to current requirements, and crosstalk between 
these two biological responses has recently been identified64. Although relatively few studies have been conducted 
in humans, animal models provide strong evidence that, in addition to the control of cell proliferation and death, 
cell cycle mediators also play key roles in the biological function of adipocytes such as insulin sensitivity, lipolysis 
and glucose transport62,63. Therefore, acute upregulation of cell cycle pathways with active breaks in prolonged 
sitting (independently of break intensity) may indicate a role for these effectors in metabolic adaptation of adipose 
tissue to physical activity. This is also characteristic of other general cellular function pathways (e.g. metabolism of 
RNA and proteins, DNA replication) which were also upregulated with breaks at both intensities.
Light intensity breaks in prolonged sitting may facilitate cross-talk between adipose and 
other organs. The configuration of adipose tissue is structured so that adipocytes are in close proximity to 
immune cells, with immediate access to a vast network of blood vessels, which allows continuous and dynamic 
interaction between immune and metabolic processes and cross-talk with other organs43. This structure and 
inter-connectivity likely contributes to the key role of adipose tissue in the development of metabolic disease43. 
Indeed, an active communication network between adipose tissue and muscle regulating glucose homeostasis is 
now well-established, whereby adipokines can increase muscle insulin sensitivity and glucose uptake via direct 
and indirect means65,66. Wnt glycoproteins are produced and released from several tissues, including white adi-
pose tissue. Wnt signaling inhibits adipogenesis and regulates whole-body metabolism by altering the behaviour 
of multiple cell types and tissues, including a role in promoting insulin sensitivity66,67. Moreover, Wnt signal-
ing activation in adipose progenitors has been shown to promote insulin-independent muscle glucose uptake65. 
Therefore, in the current study upregulation of the Wnt signaling pathway in the light-intensity breaks condition, 
compared to uninterrupted sitting, could indicate facilitation of cross-talk between the adipose tissue and other 
body organs.
Strengths and limitations. Our highly controlled study design, including within-participant comparison 
across three interventions completed in a randomized order, is a strength. The number of participants, albeit 
relatively small, was sufficient to detect significant changes in gene expression with appropriate FDR correction. 
A larger cohort may reveal a greater number of regulated genes. Similarly, we investigated only the acute effects 
of 5 hours of light- and moderate-intensity breaks from sitting and chronic interventions (multiple days/weeks) 
may show evolution in gene expression patterns. Differential effects are likely to be observed in adipose tissue 
collected from other subcutaneous (eg, gluteal) or visceral depots, although there is no evidence for site specific 
relationships in terms of substrate provision to local active muscle (spot reduction)68. It is also relevant to con-
sider the potential contribution of RNA derived from immune and endothelial cells within our adipose tissue 
samples. Generally, such components are unlikely to have contributed significantly to our observations. Adipose 
samples used in the present analysis were dissected free of connective and vascular tissue, and washed thor-
oughly minimizing any vascular component. Immune cells would however remain69, and future studies dissecting 
their potential contribution to metabolism during breaks from prolonged sitting will be important. The absolute 
fold-change criteria of 0.5 (in either direction) for selection of significant effects may result in failure to detect 
important regulated genes; however, all genes meeting the call rate criteria were included in the pathway analysis 
and therefore contributed to the overall biological interpretation of the results. False positives were minimized 
by use of repeated measures analysis to allow comparison of all three interventions, and correction for multiple 
testing with the FDR method by Benjamini-Hochberg28. Our findings provide a basis for future studies to exam-
ine the adipose tissue transcriptional networks, in various adipose depots, regulated by breaking up sedentary 
time over longer periods and their relationship to bioclinical phenotypes. In particular, studies with a larger 
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sample size and detailed measurements of glucose and fat metabolism beyond the simple plasma measurements 
employed in the current study will be necessary to substantiate the findings of the present analysis.
Conclusions
This is the first study to characterize the acute transcriptional events induced in subcutaneous abdominal adi-
pose tissue by breaking up prolonged sitting time with frequent brief activity bouts. We observed distinct and 
biologically-interpretable effects of what conventionally would be understood as an extremely modest physi-
cal activity stimulus. Interestingly, upregulation of pathways involved in oxidative metabolism and immunity 
were greater for light-intensity breaks compared to sitting, although moderate-intensity breaks showed similar 
directional trends. Our findings highlight some of the regulated mechanisms that potentially underlie the phys-
iological benefits of breaking up prolonged periods of sedentary time. We have identified candidate genes that 
may contribute to the modulationof postprandial glucose, insulin, lipid and inflammatory responses shown to 
occur with breaking up of prolonged sitting. These findings further elucidate the potential mechanistic underpin-
nings of the adverse health consequences of prolonged sitting. They add further weight to the scientific literature 
describing the potential health effects of regular, brief activity breaks in sitting (even of a light intensity), which 
could contribute to the development and extension of future public health guidelines. However larger studies with 
more detailed metabolic measures are required to corroborate the findings of the current investigation.
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